Label-Free Proteomics Reveals Decreased Expression of CD18 and AKNA in Peripheral CD4+ T Cells from Patients with Vogt-Koyanagi-Harada Syndrome
2011

Proteomics Study of CD4+ T Cells in Vogt-Koyanagi-Harada Syndrome

Sample size: 20 publication 10 minutes Evidence: moderate

Author Information

Author(s): Mao Liming, Yang Peizeng, Hou Shengping, Li Fuzhen, Kijlstra Aize

Primary Institution: Laboratory of Ophthalmology, Chongqing Eye Institute, The First Affiliated Hospital of Chongqing Medical University

Hypothesis

The study aims to identify aberrantly expressed membrane proteins in CD4+ T cells from patients with active Vogt-Koyanagi-Harada syndrome.

Conclusion

The study found significantly decreased expression of CD18 and AKNA in CD4+ T cells from patients with active VKH syndrome.

Supporting Evidence

  • Thirty proteins were identified to be at least 1.5 fold differently expressed between active VKH patients and normal individuals.
  • CD18 and AKNA were confirmed to have a more than three-fold difference in expression.
  • The expression of CD18 was about five-fold lower in active VKH patients compared to normal controls.

Takeaway

Researchers looked at blood cells from people with a specific eye disease and found that two proteins were much lower than in healthy people, which might help explain the disease.

Methodology

The study used a label-free quantitative proteomic strategy to analyze CD4+ T cells from patients and healthy controls, followed by Western blot validation.

Limitations

The study's findings need confirmation through additional techniques and may be limited by the small sample size.

Participant Demographics

The study included ten active VKH patients and eleven healthy individuals, matched for sex and age.

Statistical Information

P-Value

0.00004

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0014616

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication